SB
BLU

Samsara BioCapital’s BELLUS Health Inc. BLU Stock Holding History

Samsara BioCapital’s Portfolio BLU Stock Details BLU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-333,631
Closed -$3.45M – 42
2020
Q2 		$3.45M Sell
333,631
-60,800
-15% -$616K 1.11% 22
2020
Q1 		$3.92M Sell
394,431
-94,427
-19% -$842K 2.25% 13
2019
Q4 		$3.69M Buy
+488,858
New +$3.34M 1.77% 14

Other funds holding BLU

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Samsara BioCapital's BLU Position: Q3 2020 in Review

Samsara BioCapital sold out of BELLUS Health Inc. (BLU) in Q3 2020, closing a stake of 333,631 shares — an estimated $3.45M sold.

Samsara BioCapital first reported a position in BLU in Q4 2019 and held it in 3 quarters. The position peaked at $3.92M in Q1 2020. 50 funds tracked by Wall St. Rank hold BLU as of Q3 2020.

  • Samsara BioCapital reported no remaining BELLUS Health Inc. position as of Q3 2020 after selling out during the quarter.
  • Samsara BioCapital sold 333,631 BELLUS Health Inc. shares in Q3 2020, an estimated $3.45M.
  • Samsara BioCapital first reported a position in BELLUS Health Inc. in Q4 2019 and held it in 3 quarters.
  • Samsara BioCapital's BELLUS Health Inc. position peaked at $3.92M in Q1 2020.
  • 50 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q3 2020.

Based on Samsara BioCapital's 13F filing for Q3 2020, filed 16 Nov 2020.